Efficacy of Valsartan versus enalapril in lowering Proteinuria in patients with diabetic nephropathy.

Authors

  • Awais Asghar Allied Hospital, Faisalabad
  • Naila Unbreen Allied Hospital, Faisalabad.
  • Muhammad Owais Fazal Faisalabad Medical University, Faisalabad.
  • Ghulam Abbas Tahir FMU.
  • Muhammad Usman Musharraf FMU.

DOI:

https://doi.org/10.29309/TPMJ/2026.33.03.9978

Keywords:

Diabetic Nephropathy, Enalapril, Efficacy, Proteinuria, Valsartan

Abstract

Objective: To compare the effectiveness of valsartan and enalapril in reducing proteinuria in diabetic nephropathy patients. Study Design: Randomized Controlled Trial. Setting: Medical Floor, Allied Hospital. Period: January 3, 2024, to January 9, 2024 (Six Months). Methods: The study involved patients enrolled after approval from the Institutional Ethical Review Committee at Punjab Medical College, Faisalabad. Participants were randomly divided into two groups: Group A received valsartan 80mg daily, and Group B received enalapril 10mg daily for 3 months. Patients were monitored for efficacy after 3 months. Results: Results show no significant difference between the efficacy of the two drugs, but validation through multicenter studies is needed. Conclusion:

Author Biographies

Awais Asghar, Allied Hospital, Faisalabad

MBBS, Postgraduate Resident, 

Naila Unbreen, Allied Hospital, Faisalabad.

MBBS, FCPS (Med), Women Medical Officer, 

Muhammad Owais Fazal, Faisalabad Medical University, Faisalabad.

MBBS, MCPS, FCPS (Med), MRCP, MsPH, Associate Professor Medicine, 

Ghulam Abbas Tahir, FMU.

MBBS, FCPS, Assistant Professor Medicine, 

Muhammad Usman Musharraf, FMU.

FCPS (Med), FCPS (Endo), Senior Registrar Medicine, 

Downloads

Published

2026-03-07

Issue

Vol. 33 No. 03 (2026): Vol. 33 No. 03

Section

Origianl Article

License

Copyright (c) 2026 The Professional Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.